By Dr Philip Koopowitz – Director Dispex
The reimbursement price of Inclisiran is £60.00. In addition, the DHSC has classified that all drugs from Part VIIIC – Arrangements of Payment for Products Supplied Free of Charge or Products with a Nominal Price (England) will be Zero-discounted for general practice. It can only be purchased from AAH and the purchase price is set at £45.00 plus VAT. This is extremely good news. With a dispensing profit of £18.00 per jab dispensed, it becomes more palatable to administer it at the surgery.
The Guidance issued by NHSE was confusing and we sought clarification from NHSBSA about whether you need to charge the patient or not.
https://www.england.nhs.uk/long-read/funding-supply-inclisiran-leqvio/
The NHSBSA advise:
“We will need an FP10 to reimburse Inclisiran/Leqvio regardless of which scenario the NHSE guidance sets out. Inclisiran/Leqvio is not a high-volume vaccine and should not be added to the FP34D annex.
We would also always view each FP10 for Inclisiran/Leqvio as a regular (Personally Administered) PA item as we would not be able to identify how it was sourced and/or administered to the patient. Therefore, we would treat every FP10 for Inclisiran/Leqvio as free of charge regardless of whether the patient has paid a charge or not according to the regulations.”
